U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Dalbavancin

Last Revision: September 21, 2020.

Estimated reading time: 1 minute

CASRN: 171500-79-1

image 135109743 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Dalbavancin is 93% plasma protein bound and is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. If dalbavancin is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the infant for possible effects on the gastrointestinal tract, such as diarrhea, vomiting, and candidiasis (e.g., thrush, diaper rash).

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Dalbavancin

CAS Registry Number

171500-79-1

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Anti-Bacterial Agents

Glycopeptides

Lipoglycopeptides

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK500690PMID: 29999749

Views

Related information

Similar articles in PubMed

  • Review Vancomycin.[Drugs and Lactation Database (...]
    Review Vancomycin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Telavancin.[Drugs and Lactation Database (...]
    Review Telavancin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Oritavancin.[Drugs and Lactation Database (...]
    Review Oritavancin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Plazomicin.[Drugs and Lactation Database (...]
    Review Plazomicin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Clindamycin.[Drugs and Lactation Database (...]
    Review Clindamycin.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...